Reaction Details Report a problem with these data
Target
Vasopressin V1a receptor
Ligand
BDBM50397207
Substrate
n/a
Meas. Tech.
ChEMBL_864200 (CHEMBL2175252)
Ki
>10000±n/a nM
Citation
 Loison, S; Cottet, M; Orcel, H; Adihou, H; Rahmeh, R; Lamarque, L; Trinquet, E; Kellenberger, E; Hibert, M; Durroux, T; Mouillac, B; Bonnet, D Selective fluorescent nonpeptidic antagonists for vasopressin V2 GPCR: application to ligand screening and oligomerization assays. J Med Chem 55:8588-602 (2012) [PubMed]  Article 
Target
Name:
Vasopressin V1a receptor
Synonyms:
AVPR V1a | AVPR1 | AVPR1A | Antidiuretic hormone receptor 1a | V1AR_HUMAN | V1aR | VASOPRESSIN V1A | Vascular/hepatic-type arginine vasopressin receptor | Vasopressin V1 receptor | Vasopressin V1a receptor | Vasopressin receptor
Type:
Receptor
Mol. Mass.:
46820.18
Organism:
Homo sapiens (Human)
Description:
P37288
Residue:
418
Sequence:
MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST
  
Inhibitor
Name:
BDBM50397207
Synonyms:
CHEMBL2172288
Type:
Small organic molecule
Emp. Form.:
C66H63N9O12S
Mol. Mass.:
1206.325
SMILES:
OC(=O)c1cc(NC(=S)NCCOCCOCCOCCn2cc(CNC(=O)CCC(=O)NC3CCCN(C(=O)c4ccc(NC(=O)c5ccccc5-c5ccccc5)cc4)c4ccccc34)nn2)ccc1-c1c2ccc(O)cc2oc2cc(=O)ccc12 |(30.96,-29.16,;30.97,-27.63,;29.62,-28.36,;31.01,-26.09,;29.7,-25.29,;29.75,-23.75,;28.43,-22.94,;28.48,-21.4,;29.83,-20.67,;27.16,-20.6,;27.2,-19.06,;25.89,-18.25,;25.93,-16.71,;24.62,-15.91,;24.66,-14.37,;23.34,-13.56,;23.38,-12.02,;22.07,-11.22,;22.11,-9.68,;20.8,-8.87,;19.48,-9.65,;19.48,-11.19,;18.26,-12.12,;18.78,-13.58,;17.91,-14.85,;16.37,-14.85,;15.6,-16.19,;16.38,-17.52,;14.06,-16.19,;13.3,-17.54,;11.74,-17.54,;10.97,-16.2,;10.98,-18.88,;11.73,-20.18,;13.29,-20.17,;14.27,-21.36,;13.94,-22.87,;12.54,-23.56,;12.52,-25.13,;11.18,-25.89,;13.86,-25.9,;15.21,-25.14,;16.53,-25.91,;16.52,-27.45,;17.84,-28.22,;19.18,-27.45,;19.18,-25.91,;20.51,-28.23,;20.5,-29.78,;21.83,-30.55,;23.18,-29.78,;23.18,-28.24,;21.83,-27.46,;21.84,-25.92,;23.18,-25.16,;23.18,-23.63,;21.85,-22.85,;20.5,-23.63,;20.5,-25.16,;15.18,-28.22,;13.85,-27.45,;11.14,-22.9,;10.03,-23.98,;8.54,-23.56,;8.15,-22.04,;9.28,-20.96,;10.77,-21.39,;20.31,-13.54,;20.75,-12.06,;31.09,-23.01,;32.41,-23.81,;32.37,-25.36,;33.68,-26.15,;34.98,-25.34,;34.93,-23.82,;36.22,-23,;37.58,-23.72,;38.89,-22.91,;37.63,-25.26,;36.33,-26.06,;36.4,-27.61,;35.08,-28.42,;35.13,-29.95,;33.83,-30.76,;33.88,-32.3,;32.47,-30.03,;32.43,-28.5,;33.73,-27.69,)|
Structure:
Search PDB for entries with ligand similarity: